Clinical Study of Pulp Mesenchymal Stem Cells in the Treatment of Primary Mild to Moderate Knee Osteoarthritis
Condition: Knee Osteoarthritis Interventions: Biological: Low Dose of Mesenchymal stem cell; Biological: High Dose of Mesenchymal stem cell; Drug: Sodium Hyaluronate Sponsor: CAR-T (Shanghai) Biotechnology Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials